Original Source(s)
Related Content
CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease
An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial
April 13, 2026
-
2 min